PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmyoclonic epilepsies
MeSH D004831 - myoclonic epilepsies
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004829:Generalized epilepsy
0 Companies
0 Drugs
Success rate
D000073376:Epileptic syndromes
1 Company
1 Drug
$
Success rate
D004831: 
Myoclonic epilepsies
17 Companies
3 Drugs
$
Success rate
D020190:Juvenile myoclonic epilepsy
69 Companies
2 Drugs
$
Success rate
D020191:Progressive myoclonic epilepsies
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
75%
3/4
Phase 3
67%
6/9
Approved: 4Overall Success rate: 50%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Clonazepam
Jazz Pharmaceuticals
Cannabidiol,
Benzocaine,
Aspartame,
Nabiximols,
Sucralose,
Antineoplaston a10
UCB
Fenfluramine,
Aspartame
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use